Literature DB >> 7871641

Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines.

Y Mizutani1, B Bonavida, O Yoshida.   

Abstract

Treatment of renal cell carcinoma (RCC) by conventional chemotherapy and immunotherapy has resulted in minimal remissions. Alternative forms of therapy are therefore being sought. The present study investigated the sensitivity of RCC cell lines to several toxins used alone and in combination with other agents. RCC lines were relatively sensitive to the direct cytotoxic effect of diphtheria toxin (DTX), Pseudomonas aeruginosa exotoxin A (PEA) and ricin. Furthermore, DTX in combination with tumor necrosis factor-alpha (TNF-alpha) resulted in synergistic cytotoxic activity. The mechanism of synergy was examined. A possible mechanism of resistance to TNF-alpha in tumor cells is the expression of TNF-alpha mRNA or protein. R11 cells did not constitutively express mRNA for TNF-alpha, however, treatment of R11 cells with TNF-alpha induced the expression of TNF-alpha mRNA. When DTX was used in combination with TNF-alpha, the level of TNF-alpha mRNA induced by TNF-alpha was markedly reduced. These studies suggest that DTX in combination with TNF-alpha can overcome the resistance of RCC lines and that the marked downregulation of TNF-alpha mRNA by DTX may play a role in the enhanced cytotoxicity seen with the combination of DTX and TNF-alpha. Furthermore, the combination treatment might also potentiate the antitumor host responses. The implications of these findings in clinical therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7871641     DOI: 10.1007/BF00541904

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  37 in total

1.  Second cytotoxic pathway of diphtheria toxin suggested by nuclease activity.

Authors:  M P Chang; R L Baldwin; C Bruce; B J Wisnieski
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

2.  Overcoming tnf-alpha and cddp resistance of a human ovarian-cancer cell-line (c30) by treatment with buthionine sulfoximine in combination with tnf-alpha and or cddp.

Authors:  Y Mizutani; B Bonavida
Journal:  Int J Oncol       Date:  1993-08       Impact factor: 5.650

Review 3.  Chemotherapy of renal cell carcinoma: 1983-1989.

Authors:  A Yagoda
Journal:  Semin Urol       Date:  1989-11

Review 4.  Failure of cytotoxic chemotherapy, 1983-1988, and the emerging role of monoclonal antibodies for renal cancer.

Authors:  A Yagoda; N H Bander
Journal:  Urol Int       Date:  1989       Impact factor: 2.089

5.  Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.

Authors:  H Baisch; U Otto; G Klöppel
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

Review 6.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

7.  Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.

Authors:  Y Mizutani; O Yoshida
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

8.  Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.

Authors:  Y Mizutani; B Bonavida
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

9.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

10.  STUDIES ON THE MODE OF ACTION OF DIPHTHERIA TOXIN. II. EFFECT OF TOXIN ON AMINO ACID INCORPORATION IN CELL-FREE SYSTEMS.

Authors:  R J COLLIER; A M PAPPENHEIMER
Journal:  J Exp Med       Date:  1964-12-01       Impact factor: 14.307

View more
  2 in total

1.  Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.

Authors:  K A Delviks; W S Hu; V K Pathak
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences.

Authors:  Aya Mizrahi; Abraham Hochberg; Smadar Amiur; Jennifer Gallula; Imad Matouk; Tatiana Birman; Tally Levy; Sorin Ladimir; Patricia Ohana
Journal:  Int J Clin Exp Med       Date:  2010-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.